참고문헌
- Ali, H., Du, Z., Li, X., Yang, Q., Zhang, Y.C., Wu, M., Li, Y., and Zhang, G. (2015). Identification of suitable reference genes for gene expression studies using quantitative polymerase chain reaction in lung cancer in vitro. Mol. Med. Rep. 11, 3767-3773. https://doi.org/10.3892/mmr.2015.3159
- Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A.A., Kim, S., Wilson, C.J., Lehar, J., Kryukov, G.V., Sonkin, D., et al. (2012). The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603-607. https://doi.org/10.1038/nature11003
- Cancer Genome Atlas Research Network, Weinstein, J.N., Collisson, E.A., Mills, G.B., Shaw, K.R., Ozenberger, B.A., Ellrott, K., Shmulevich, I., Sander, C., and Stuart, J.M. (2013). The Cancer Genome Atlas Pan-cancer analysis project. Nat. Genet. 45, 1113-1120. https://doi.org/10.1038/ng.2764
- Carretero, J., Medina, P.P., Pio, R., Montuenga, L.M., and Sanchez-Cespedes, M. (2004). Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene. Oncogene 23, 4037-4040. https://doi.org/10.1038/sj.onc.1207502
- Chen, L., Engel, B.E., Welsh, E.A., Yoder, S.J., Brantley, S.G., Chen, D.T., Beg, A.A., Cao, C., Kaye, F.J., Haura, E.B., et al. (2016). A sensitive NanoStringbased assay to score STK11 (LKB1) pathway disruption in lung adenocarcinoma. J. Thorac. Oncol. 11, 838-849. https://doi.org/10.1016/j.jtho.2016.02.009
- Clough, E. and Barrett, T. (2016). The gene expression omnibus database. In Statistical Genomics, E. Mathe and S. Davis, eds. (New York: Humana Press), pp. 93-110.
- Facchinetti, F., Bluthgen, M.V., Tergemina-Clain, G., Faivre, L., Pignon, J.P., Planchard, D., Remon, J., Soria, J.C., Lacroix, L., and Besse, B. (2017). LKB1/STK11 mutations in non-small cell lung cancer patients: descriptive analysis and prognostic value. Lung Cancer 112, 62-68. https://doi.org/10.1016/j.lungcan.2017.08.002
- Gao, Y., Xiao, Q., Ma, H., Li, L., Liu, J., Feng, Y., Fang, Z., Wu, J., Han, X., Zhang, J., et al. (2010). LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proc. Natl. Acad. Sci. U. S. A. 107, 18892-18897. https://doi.org/10.1073/pnas.1004952107
- Gill, R.K., Yang, S.H., Meerzaman, D., Mechanic, L.E., Bowman, E.D., Jeon, H.S., Roy Chowdhuri, S., Shakoori, A., Dracheva, T., Hong, K.M., et al. (2011). Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer. Oncogene 30, 3784-3791. https://doi.org/10.1038/onc.2011.98
- He, N., Kim, N., Song, M., Park, C., Kim, S., Park, E.Y., Yim, H.Y., Kim, K., Park, J.H., and Kim, K.I. (2014). Integrated analysis of transcriptomes of cancer cell lines and patient samples reveals STK11/LKB1-driven regulation of cAMP phosphodiesterase-4D. Mol. Cancer Ther. 13, 2463-2473. https://doi.org/10.1158/1535-7163.MCT-14-0297
- Ho, J.A., Chang, H.C., Shih, N.Y., Wu, L.C., Chang, Y.F., Chen, C.C., and Chou, C. (2010). Diagnostic detection of human lung cancer-associated antigen using a gold nanoparticle-based electrochemical immunosensor. Anal. Chem. 82, 5944-5950. https://doi.org/10.1021/ac1001959
- Isgro, M.A., Bottoni, P., and Scatena, R. (2015). Neuron-specific enolase as a biomarker: biochemical and clinical aspects. In Advances in Cancer Biomarkers, R. Scatena, ed. (Dordrecht, The Netherlands: Springer), pp. 125-143.
- Kim, N., Yim, H.Y., He, N., Lee, C.J., Kim, J.H., Choi, J.S., Lee, H.S., Kim, S., Jeong, E., and Song, M. (2016). Cardiac glycosides display selective efficacy for STK11 mutant lung cancer. Sci. Rep. 6, 29721. https://doi.org/10.1038/srep29721
- Liu, D.W., Chen, S.T., and Liu, H.P. (2005). Choice of endogenous control for gene expression in nonsmall cell lung cancer. Eur. Respir. J. 26, 1002-1008. https://doi.org/10.1183/09031936.05.00050205
- Liu, K.J. and Shih, N.Y. (2007). The role of enolase in tissue invasion and metastasis of pathogens and tumor cells. J. Cancer Mol. 3, 45-48.
-
Lung, J., Chen, K.L., Hung, C.H., Chen, C.C., Hung, M.S., Lin, Y.C., Wu, C.Y., Lee, K.D., Shih, N.Y., and Tsai, Y.H. (2017). In silico-based identification of human
${\alpha}$ -enolase inhibitors to block cancer cell growth metabolically. Drug Des. Devel. Ther. 11, 3281-3290. https://doi.org/10.2147/DDDT.S149214 - Muller, F.L., Colla, S., Aquilanti, E., Manzo, V.E., Genovese, G., Lee, J., Eisenson, D., Narurkar, R., Deng, P., and Nezi, L. (2012). Passenger deletions generate therapeutic vulnerabilities in cancer. Nature 488, 337-342. https://doi.org/10.1038/nature11331
- Novello, S., Barlesi, F., Califano, R., Cufer, T., Ekman, S., Levra, M.G., Kerr, K., Popat, S., Reck, M., Senan, S., et al. (2016). Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 27(Suppl 5), v1-v27. https://doi.org/10.1093/annonc/mdw326
- Peshavaria, M. and Day, I.N. (1991). Molecular structure of the human muscle-specific enolase gene (ENO3). Biochem. J. 275, 427-433. https://doi.org/10.1042/bj2750427
- Planchard, D., Popat, S., Kerr, K., Novello, S., Smit, E.F., Faivre-Finn, C., Mok, T.S., Reck, M., Van Schil, P.E., Hellmann, M.D., et al. (2018). Metastatic nonsmall cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 29(Suppl 4), iv192-iv237. https://doi.org/10.1093/annonc/mdy275
- Song, M., Lee, H., Nam, M.H., Jeong, E., Kim, S., Hong, Y., Kim, N., Yim, H.Y., Yoo, Y.J., Kim, J.S., et al. (2017). Loss-of-function screens of druggable targetome against cancer stem-like cells. FASEB J. 31, 625-635. https://doi.org/10.1096/fj.201600953
피인용 문헌
- Prognostic Value of Enolase Gene Family in Colon Cancer vol.26, 2019, https://doi.org/10.12659/msm.922980
- Human papillomavirus 16 ( HPV 16) E6 but not E7 inhibits the antitumor activity of LKB1 in lung cancer cells by downregulating the expression of KIF7 vol.11, pp.11, 2019, https://doi.org/10.1111/1759-7714.13640
- Analysis of Cross-Association between mRNA Expression and RNAi Efficacy for Predictive Target Discovery in Colon Cancers vol.12, pp.11, 2020, https://doi.org/10.3390/cancers12113091
- The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction vol.12, pp.23, 2019, https://doi.org/10.18632/aging.104134
- ENO3 Inhibits Growth and Metastasis of Hepatocellular Carcinoma via Wnt/β-Catenin Signaling Pathway vol.9, 2021, https://doi.org/10.3389/fcell.2021.797102
- Identification of Clinical and Tumor Microenvironment Characteristics of Hypoxia-Related Risk Signature in Lung Adenocarcinoma vol.8, 2019, https://doi.org/10.3389/fmolb.2021.757421
- Identification of Five Glycolysis-Related Gene Signature and Risk Score Model for Colorectal Cancer vol.11, 2019, https://doi.org/10.3389/fonc.2021.588811
- MicroRNA‑106a‑5p promotes the proliferation, autophagy and migration of lung adenocarcinoma cells by targeting LKB1/AMPK vol.22, pp.6, 2019, https://doi.org/10.3892/etm.2021.10857
- Q-omics: Smart Software for Assisting Oncology and Cancer Research vol.44, pp.11, 2019, https://doi.org/10.14348/molcells.2021.0169
- Exploring exosome data to identify prognostic gene signatures for lung adenocarcinoma vol.17, pp.34, 2021, https://doi.org/10.2217/fon-2021-0261